Insomnia
Conditions
Interventions
Medication control group:Oral benzodiazepine medications
Control group:Conventional acupuncture
Experimental group: "Xingnao Kaiqiao" Acupuncture
Sponsors
Chengdu Integrated TCM&Western Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Participants must meet the diagnostic criteria for both sub-health status and insomnia with the condition persisting for more than 3 months. (1) The diagnostic criteria for sub-health status are based on the 2006 *Clinical Guidelines for Sub-health in Traditional Chinese Medicine*: 1) Predominant physical symptoms such as fatigue sleep disturbances or pain; 2) Predominant psychological symptoms such as depression anxiety irritability fear short-term memory decline or difficulty concentrating; 3) Predominant decline in social adaptability such as reduced frequency of social interactions or strained interpersonal relationships. Any one of the above three conditions lasting for more than 3 months with systemic examinations ruling out other diseases that may cause these manifestations. (2) The diagnostic criteria for insomnia are based on the *People's Medical Publishing House·Neurology·Second Edition*: 1) Complaints of insomnia including difficulty falling asleep (taking more than 30 minutes to fall asleep) frequent awakenings (more than twice per night) vivid dreams early morning awakenings or difficulty falling back asleep after waking up (taking more than 30 minutes to fall back asleep); 2) Impaired social functioning with daytime symptoms such as dizziness fatigue sleepiness difficulty concentrating and reduced work performance; 3) The above symptoms occur more than 3 times per week and persist for at least 1 month. 2.2 Athens Insomnia Scale score > 7; 2.3 Age between 18 and 65 years; no gender restrictions; approved by the medical ethics committee and voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women or individuals unable to express their own sensations; (2) Those with severe cardiac hepatic or renal dysfunction or severe heart disease; (3) Individuals who have received any relevant treatment within the past 2 weeks; (4) Those with a history of drug or alcohol abuse or a history of mental illness; (5) Individuals with metal implants in the skull or those with implanted devices such as pulse generators cardiac pacemakers implantable drug pumps implantable defibrillators or implantable neurostimulators as well as those with cochlear implants; (6) Individuals with skull defects increased intracranial pressure hearing impairment or a personal or family history of epilepsy; (7) Those who refuse to participate withdraw midway from the study or fail to sign the informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality IndexPSQI; | — |
Secondary
| Measure | Time frame |
|---|---|
| sleep efficiency;Self-Rating Depression Scale;Standard for Improvement of TCM Syndromes;Cerebral Cortex Excitability;Self-Rating Anxiety Scale; | — |
Countries
China
Contacts
Public ContactHou Tianshu
Chengdu Integrated TCM&Western Medicine Hospital
Outcome results
None listed